The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome

The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome

In many developing countries, Measles–Mumps–Rubella (MMR) vaccine is available through the private but not the public sectors, and there is no systematic rubella vaccination among adult women. In this paper, we extend previous modeling studies to demonstrate that in developing countries with a mediu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2003-06, Vol.21 (21), p.2708-2719
Hauptverfasser: Vynnycky, E., Gay, N.J., Cutts, F.T.
Format: Artikel
Sprache:eng
Schlagworte:
Adult
Autism
Biological and medical sciences
Children & youth
Congenital Rubella Syndrome
Developing Countries
Female
Human viral diseases
Humans
Immunization Programs
Infectious diseases
LDCs
Male
Mathematical model
Measles
Measles-Mumps-Rubella Vaccine - therapeutic use
Medical sciences
MMR vaccination
Mumps
Private Sector
Rubella Syndrome, Congenital - epidemiology
Rubella Syndrome, Congenital - prevention & control
Time Factors
Transmission dynamics
Tropical medicine
Vaccination
Vaccines
Viral diseases
Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In many developing countries, Measles–Mumps–Rubella (MMR) vaccine is available through the private but not the public sectors, and there is no systematic rubella vaccination among adult women. In this paper, we extend previous modeling studies to demonstrate that in developing countries with a medium–high force of infection (200–400/1000 per year), current levels of private sector MMR coverage (
ISSN:0264-410X
1873-2518
DOI:10.1016/S0264-410X(03)00229-9